Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0000950170-24-027249

SVP, Business Development sold 17,411 shares at an average $4.21 ($73,379)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Birznieks Gunther SVP, Business Development 2024-03-04 Sale −8,727 $4.30 $37,495 322,253 D: show line 1 in the form
Birznieks Gunther SVP, Business Development 2024-03-05 Sale −8,684 $4.13 $35,884 313,569 D: show line 2 in the form
Open-market sales · 17,411 sh · avg $4.21 · $73,379
Loading xslF345X05/ownership.xml…